List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1085 studies with search of: Russian Federation
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
Condition: Malignant Melanoma
Intervention: Drug: HSPPC-96 or Oncophage
2 Terminated Open-Label Trial of LEUKINE® in Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Sargramostim (Leukine, BAY86-5326)
3 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
4 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
5 Completed Efficacy and Safety of BG00012 in MS
Condition: Multiple Sclerosis
Intervention: Drug: BG00012
6 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
7 Completed Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexol Extended Release;   Drug: Pramipexol Immediate Release;   Drug: Placebo
8 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
9 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
10 Recruiting Efficacy and Safety Study of BERIPLEX® P/N Compared With Plasma in Patients on Anticoagulant Therapy Who Require Emergency Surgery or Invasive Intervention
Condition: Reversal of Coagulopathy
Interventions: Biological: Beriplex® P/N;   Biological: Fresh frozen plasma
11 Recruiting A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: duloxetine;   Drug: Placebo;   Drug: fluoxetine
12 Completed BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Copaxone
13 Recruiting Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Conditions: Cardiovascular Diseases;   Heart Diseases;   Heart Failure, Congestive
Interventions: Drug: Aldosterone Antagonist (spironolactone);   Drug: Placebo
14 Active, not recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
15 Completed Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Roflumilast;   Drug: Placebo
16 Recruiting Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Tenofovir;   Drug: Adefovir;   Drug: Lamivudine
17 Recruiting Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
18 Recruiting Atacicept in Multiple Sclerosis, Phase II
Condition: Relapsing Multiple Sclerosis
Interventions: Drug: atacicept;   Drug: Placebo
19 Terminated A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
Conditions: Pain;;   Bone Neoplasms;;   Neoplasm Metastasis
Interventions: Drug: ibandronate [Bondronat];   Drug: zoledronic acid
20 Active, not recruiting Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: AVODART;   Drug: Tamsulosin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services